RYPLAZIM

View On IC.GC.CA

REGISTERED

on 4 Jul 2019

Last Applicant/ Owned by

PROMETIC BIOTHERAPEUTICS INC. A DELAWARE CORPORATION

1330 Piccard Drive, Suite 201Rockville, MD 20850

Serial Number

1811304 filed on 25^th Nov 2016

Registration Number

TMA1035916 registered on 4^th Jul 2019

Registration expiry Date

4^th Jul 2029

Correspondent Address

MACRAE & CO.

326 Somerset Street WestOttawa

ONTARIO

K2P0J9

RYPLAZIM

Trademark usage description

pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies, namely, plasminogen replacement therapy

Classification Information

1811304

Trademark

Action Taken	Status
Submitted for opposition 50 on 8^th Jun 2018	Allowed
Submitted for opposition 51 on 8^th Jun 2018	Allowance Notice Sent
Submitted for opposition 42 on 21^st Feb 2018	Advertised
Submitted for opposition 26 on 1^st Feb 2018	Approved
Submitted for opposition 27 on 14^th Dec 2017	Approval Notice Sent
Submitted for opposition 22 on 20^th Oct 2017	Search Recorded
Submitted for opposition 20 on 20^th Oct 2017	Examiner's First Report
Submitted for opposition 31 on 29^th Nov 2016	Formalized
Submitted for opposition 1 on 28^th Nov 2016	Created
Submitted for opposition 30 on 25^th Nov 2016	Filed